Conclusions: Discontinuation of antiplatelet therapy was identified in some patients as a reason for BVS thrombosis, however, in the majority of the cases mechanical factors were identified by OCT as a substrate. OCT can provide useful insights on the pathomechanisms of this complication. Background: Stent thrombosis (ST) has been described as a rare event in current drug-eluting stent (DES) era; however, its occurrence has been associated with high morbimortality, including fatality rates up to 50%. Previous studies have shown ST could be increased in complex subsets; however, the incidence and predictors of ST after DES overtime are still no fully understood Methods: A total of 5,408 pts with >8,000 coronary lesions undergoing routine or emergency PCI were prospectively (and consecutively) enrolled in the DESIRE (Drug-Eluting Stent In the REal World) registry at single institution between May/ 2002 and May/2012 (enrollment ongoing). By protocol, clinical follow-up was performed at 1 and 6 months, and yearly up to 12 years post-index procedure (97%). Stent thrombosis (ST) was defined according to the propositions of the Academic Research Consortium. Results: Mean age was 65 years, 32% had diabetes, and 16% had clinical presentation of recent myocardial infarction (MI) (< 30 days). Overall, patients were treated with approximately 8,500 DES and angiographic success was high (>99%) despite relatively high complexity in the majority of lesions (67% type B2/C). Up to 12 years (median 4.9 years) FU, cumulative incidence of ST was 2.4%, given that 95.1% of patients were ST-free at 10 years (Kaplan-Meier survival curve). Of the 113 ST reported, 13% occured up to 30 days, 55% were definite ST (ARC), and >60% occured 12 months. Independent predictors of ST are shown in the 
